True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to gain weight. The FDA and CDC jointly recommended to pause use of the ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

As weight loss injections dominate the headlines, many wonder whether these so-called miracle drugs are truly safe, what ...

A 2023 test showing that Novo Nordisk (NYSE: NVO )’s Wegovy weight-loss medication not only helped people lose weight but ...

COMMENT: Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes ...

Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes Charlotte ...

Two in three adults could be obese by 2050 World Heart Report warns - More than 800 million people are said to be living with ...

May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...

On Wall Street, Charter Communications rose 1.8% after it said it agreed to merge with Cox Communications in a deal that ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...